Lebeuf et al.
JOCFeatured Article
7.18-7.12 (m, 3H), 6.31-6.18 (m, 2H), 5.70-5.58 (m, 2H), 3.13
(q, J = 7.5 Hz, 2H), 3.01-2.95 (m, 2H), 2.93 (s, 2H), 1.31 (t, J =
7.1 Hz, 3H); 13C NMR (CDCl3, 75.5 MHz) δ (ppm) 137.2, 130.1,
129.3, 128.8, 128.3, 125.3, 124.2, 119.8, 117.0, 46.9, 41.2, 30.6,
26.0, 8.1; MS (ESI) m/z 325 [M þ Na]þ (100); HRMS (ESI) calcd
for C16H18N2O2NaS [M þ Na]þ 325.0987, found 325.0977.
Anal. Calcd for C16H18N2O2S (302.1): C, 63.55; H, 6.00; N,
9.26; S, 10.60. Found: C, 63.56; H, 6.03; N, 9.12; S, 10.24.
Ethanesulfonic Acid (6-Cyanomethyl-2-methoxy-6-phenyl-
cyclohexa-1,4-dienyl)amide (37). Compound 37 was synthesized
according to the general procedure from biaryl 36 (0.5 g, 1.71
mmol, 1 equiv), THF (10 mL), n-BuLi (1 mL, 1.881 mmol, 1.1
equiv), ammonia (approximately 20 mL), lithium (29.8 mg,
4.27 mmol, 2.5 equiv), chloroacetonitrile (387 mg, 5.13 mmol,
3 equiv), and THF (5 mL). Purification by flash chromatography
(silica gel, petroleum ether/EtOAc 80/20) afforded 37 as a yellow
oil (0.349 g, 60%): IR (film, NaCl) νmax (cm-1) 3263, 2941, 2361,
1687, 1494, 1415, 1316, 1238, 1135, 1038, 888; 1H NMR (CDCl3,
300 MHz) δ (ppm) 7.38-7.28 (m, 2H), 7.23-7.19 (m, 2H),
6.89-6.85 (m, 1H), 5.94-5.88 (m, 1H), 5.64-5.61(m, 1H), 3.62
(s, 3H), 3.27-3.10 (m, 2H), 3-2.91 (m, 2H), 2,48 (q, J = 4.5 Hz,
2H), 1.24 (t, J =7.5 Hz, 3H); 13C NMR (CDCl3, 75.5 MHz) δ
(ppm) 149.9, 141.1, 130.8, 129.1, 127.9, 127.3, 122.50, 117.9,
112.8, 55.1, 48.5, 48.4, 27.2, 26.7, 8.4; MS (ESI) m/z 355 (100)
[M þ Na]þ, 200 (20) [C13H13NO þ H]þ; HRMS (ESI) calcd for
C17H20N2O3NaS [M þ Na]þ 355.1086, found 355.1082.
chromatography (silica gel, petroleum ether/EtOAc 90/10)
afforded 40j as a yellow oil (2.45 g, 60%): IR (solid, KBr) νmax
(cm-1) 2940, 1718, 1664, 1486, 1342, 1153, 996; 1H NMR (CDCl3,
300 MHz) δ (ppm) 7.58-7.56 (m, 1H), 7.55-7.50 (m, 1H),7.36-
7.33 (m, 1H), 7.25-7.22 (m, 1H), 7.11-7.08 (m, 1H), 6.09-6.02
(m, 2H), 5.56-5.53 (m, 2H), 4.41 (t, J = 4.5 Hz, 1H), 3.30 (s, 6H),
3.10 (q, J = 7.5 Hz, 2H), 2.95-2.87 (m, 2H), 2.23 (d, J = 4.1 Hz,
2H), 1.29 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 75.5 MHz) δ
(ppm) 137.8, 132.5, 131.0, 128.5, 126.3, 125.3, 124.0, 119.3, 102.7,
53.1, 46.4, 43.6, 41.1, 25.7, 8.1; MS (ESI) m/z 374 [M þ Na]þ (100);
HRMS (ESI) calcd for C18H25NO4NaS [M þ Na]þ 374.1402,
found 374.1399.
N-(2-(1-(2-(Ethylsulfonamido)phenyl)cyclohexa-2,5-dienyl)-
ethyl)-4-methylbenzenesulfonamide (42b). Compound 42b was
synthesized according to the general procedure from biaryl
34e (500 mg, 1.91 mmol, 1 equiv), THF (7 mL), n-BuLi
(0.95 mL, 2.1 mmol, 1.1 equiv), ammonia (approximately
14 mL), lithium (33 mg, 4.77 mmol, 2.5 equiv), 1-tosylaziridine
(942 mg, 4.77 mmol, 2.5 equiv), and THF (4 mL). Purification
by flash chromatography (silica gel, petroleum ether/EtOAc
80/20) afforded 42b as a pale pinky solid (341 mg, 40%): mp
140.3-141.6 °C; IR (film, NaCl) νmax (cm-1) 3283, 1598, 1441,
1318, 1145, 1084, 894, 809; 1H NMR (300 MHz, CDCl3) δ
(ppm) 7.74 (d, J=7.14 Hz, 2H), 7.52 (d, J=7.89 Hz, 1H), 7.32-
7.20 (m, 4H), 7.04 (t, J=7.71 Hz,1H), 6.02 (d, J=8.47 Hz, 2H),
5.39 (d, J=9.78 Hz, 2H), 3.11-3.01 (m, 4H), 2.76 (q, Jab
=
4.20 Hz, 2H), 2.42 (s, 3H), 2.06 (t, J=7.53 Hz, 2H), 1.27 (t, J= 7.33
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ (ppm) 143.6, 137.6, 137.1,
132.3, 130.1, 129.9, 128.6, 127.2, 126.8, 126.1, 124.0, 119.3, 46.5,
41.6, 39.6, 39.0, 25.8, 21.6, 8.1; MSMS (ESI) m/z 183 (39), 192 (32)
[M þ Na - CH2CH2NHTs-SO2Et]þ, 206 (43), 235 (52) [M þ Na
- Ts-SO2Et]þ, 284 (100) [M þ Na - CH2CH2NHTs]þ, 352 (19)
[M - SO2Et]þ, 389 (65) [M þ Na - HSO2Et]þ, 483 (59) [M þ
Na]þ; HRMS (ESI) calcd for C23H28N2O4S2Na [M þ Naþ]
483.1382, found 483.1394.
1-(tert-Butylcyclohexa-2,5-dienyl)benzene (40g). Compound
40g was synthesized according to the general procedure from
biaryl 7 (2 g, 12.97 mmol, 1 equiv), THF (40 mL), ammonia
(approximately 80 mL), lithium (209 mg, 29.83 mmol, 2.3
equiv), tert-butyl bromide (3.6 mL, 32.42 mmol, 2.5 equiv),
and THF (18 mL). Purification by flash chromatography (silica
gel petroleum ether 100%) afforded an analytic sample of 40g as
a colorless oil: IR (film, NaCl) νmax (cm-1) 3034, 2965, 2873,
1
1597, 1495, 1391, 1362, 948. H NMR (300 MHz, CDCl3) δ
(ppm) 7.41-7.17 (m, 5H), 6.47 (d, J = 10.72 Hz, 2H), 5.95 (dd,
J = 3.16, 7.32 Hz, 2H), 2.61 (AB, Jab = 36 Hz, 2H), 0.96 (s, 9H);
13C NMR (75 MHz, CDCl3) δ (ppm) 146.2, 130.1, 128.2, 127.4,
125.5, 124.8, 47.4, 37.7, 26.6, 26.4; MS (ESI) m/z 319.06 (100)
[M þ Ag]þ; HRMS (ESI) calcd for C16H20Ag [M þ Ag]þ
319.0610, found 319.0615.
N-(2-(1-(2,2-Dimethoxyethyl)cyclohexa-2,5-dienyl)phenyl)-
ethanesulfonamide (40j). Compound 40j was synthesized accord-
ing to the general procedure from biaryl 34e (3 g,
11.5 mmol, 1 equiv), THF (60 mL), n-BuLi (6.02 mL, 12.65 mmol,
1.1 equiv), ammonia (approximately 120 mL), lithium (200 mg,
28.7 mmol, 2.5 equiv), 2-bromo-1,1-dimethoxyethane (5.83 mg,
34.5 mmol, 3 equiv), and THF (15 mL). Purification by flash
Acknowledgment. We thank the CNRS for financial sup-
port, MNERT for grants to R.L., J.D., and G.B., as well as
UNESCO for a Ph.D. grant to D.I. We gratefully acknow-
ledge J.-C. Lartigue and C. Vitry for NMR and mass
spectrometry experiments.
Supporting Information Available: Experimental proce-
dures and spectroscopic data for compounds not described in
the Experimental Section and copies of 1H and 13C NMR
spectra for all new compounds. This material is available free
6478 J. Org. Chem. Vol. 74, No. 17, 2009